3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Lung Neoplasms
25
Prostatic Neoplasms
23
Carcinoma, Non-Small-Cell Lung
15
Multiple Myeloma
14
Sarcoma
12
Leukemia, Myeloid, Acute
12
Breast Neoplasms
12
Lymphoma, Non-Hodgkin
10
Glioma
10
Wilms Tumor
9
Colorectal Neoplasms
9
Carcinoma, Hepatocellular
9
Rectal Neoplasms
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Ovarian Neoplasms
8
Osteosarcoma
8
Neuroblastoma
8
Neoplasm Metastasis
8
Myelodysplastic Syndromes
8
Rhabdomyosarcoma
7
Rhabdoid Tumor
7
Pancreatic Neoplasms
7
Medulloblastoma
7
Hepatoblastoma
7
Neuroectodermal Tumors, Primitive, Peripheral
6
Mouth Neoplasms
6
Melanoma
6
Lymphoma
6
Histiocytosis, Langerhans-Cell
6
Head and Neck Neoplasms
6
Interventions
Zoledronic Acid
16
Risedronic Acid
9
Vitamin D
8
Calcium
8
Letrozole
6
Cholecalciferol
5
Calcium Carbonate
5
Alendronate
5
Denosumab
4
Absorptiometry, Photon
4
Calcium Gluconate
3
parathyroid hormone-related peptide (1-36)
2
bicalutamide
2
Resistance Training
2
Progesterone
2
Nutrition Assessment
2
Kyphoplasty
2
Hormone Replacement Therapy
2
Goserelin
2
Estradiol
2
Calcium Citrate
2
xian ling gu bao
1
romosozumab
1
X-Rays
1
Toremifene
1
Testosterone
1
Technetium
1
Spectrum Analysis
1
Raloxifene Hydrochloride
1
Radiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Osteoporosis
×
X-Rays
×
Clear all
NCT01250314
2012-07-03
OSTEHOM
Assistance Publique - Hôpitaux de Paris
Phase NA
Completed
79 enrolled